Guangdong Jiaying Pharmaceutical Co Ltd Strategic Asset Allocation Index
Guangdong Jiaying Pharmaceutical Co Ltd strategic asset allocation index. Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Strategic Asset Allocation Index of 25.9% as of September 2023. Strategic assets (PP&E of CN¥194.34 Million plus long-term investments of CN¥-) total CN¥194.34 Million, measured against net assets of CN¥751.78 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Guangdong Jiaying Pharmaceutical Co Ltd (002198) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guangdong Jiaying Pharmaceutical Co Ltd (2006–2021)
Strategic asset allocation index of Guangdong Jiaying Pharmaceutical Co Ltd from 2006 to 2021. This chart shows how Guangdong Jiaying Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2006 to 2021. As of September 2023, the index stands at 25.9%, representing strategic assets of CN¥194.34 Million against net assets of CN¥751.78 Million CNY. Check 002198 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Guangdong Jiaying Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2006–2021)
Guangdong Jiaying Pharmaceutical Co Ltd strategic asset allocation index by year from 2006 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Guangdong Jiaying Pharmaceutical Co Ltd from 2006 to 2021, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guangdong Jiaying Pharmaceutical Co Ltd stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 32.8% | CN¥224.19 Million | CN¥224.19 Million | CN¥- | CN¥684.48 Million | ▼ -3.2 pp |
| 2020 | 36.0% | CN¥245.78 Million | CN¥245.78 Million | CN¥- | CN¥683.01 Million | ▼ -2.6 pp |
| 2019 | 38.5% | CN¥255.56 Million | CN¥255.56 Million | CN¥- | CN¥663.17 Million | ▲ +2.9 pp |
| 2018 | 35.6% | CN¥279.69 Million | CN¥252.15 Million | CN¥27.54 Million | CN¥785.35 Million | ▼ -3.2 pp |
| 2017 | 38.8% | CN¥291.00 Million | CN¥264.99 Million | CN¥26.02 Million | CN¥749.81 Million | ▲ +10.1 pp |
| 2016 | 28.7% | CN¥282.55 Million | CN¥261.33 Million | CN¥21.22 Million | CN¥984.87 Million | ▼ -2.7 pp |
| 2015 | 31.4% | CN¥291.67 Million | CN¥275.14 Million | CN¥16.53 Million | CN¥929.70 Million | ▲ +3.0 pp |
| 2014 | 28.4% | CN¥244.97 Million | CN¥244.97 Million | CN¥- | CN¥863.35 Million | ▼ -0.1 pp |
| 2013 | 28.5% | CN¥230.78 Million | CN¥230.78 Million | CN¥- | CN¥809.66 Million | ▼ -25.4 pp |
| 2012 | 53.9% | CN¥149.90 Million | CN¥149.90 Million | CN¥- | CN¥278.08 Million | ▼ -3.7 pp |
| 2011 | 57.6% | CN¥155.87 Million | CN¥155.87 Million | CN¥- | CN¥270.51 Million | ▼ -4.1 pp |
| 2010 | 61.7% | CN¥159.60 Million | CN¥159.60 Million | CN¥- | CN¥258.47 Million | ▲ +7.1 pp |
| 2009 | 54.6% | CN¥131.88 Million | CN¥131.88 Million | CN¥- | CN¥241.42 Million | ▲ +21.8 pp |
| 2008 | 32.8% | CN¥74.34 Million | CN¥74.34 Million | CN¥- | CN¥226.35 Million | ▲ +8.0 pp |
| 2007 | 24.8% | CN¥52.78 Million | CN¥52.78 Million | CN¥- | CN¥212.62 Million | ▼ -31.3 pp |
| 2006 | 56.1% | CN¥46.39 Million | CN¥46.39 Million | CN¥- | CN¥82.63 Million | — |